GlassScriptPhysician profile
Kyle S Schneweis
NPI 1174834378
$567.66
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $105.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $136.22 | 2019 | |
| Amgen INC. | $76.71 | 2019-2020 | |
| Cranial Technologies, INC | $44.76 | 2019-2020 | |
| Genentech USA, INC. | $42.92 | 2019-2020 | |
| Grifols USA, LLC | $42.57 | 2019 | |
| Novo Nordisk INC | $39.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $37.38 | 2019-2020 | |
| Pfizer INC. | $33.44 | 2019 | |
| Allergan, INC. | $20.00 | 2019 | |
| Fidia Pharma USA INC. | $18.27 | 2019 | |
| Merck Sharp & Dohme LLC | $15.14 | 2019 | |
| Boston Scientific Corporation | $13.11 | 2019 | |
| Circassia INC. | $12.38 | 2019 | |
| Sanofi Pasteur INC. | $12.03 | 2019 | |
| Antares Pharma, INC. | $11.94 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Schneweis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.